[go: up one dir, main page]

BR0117191A - Composições nanoparticuladas de isotretinoina - Google Patents

Composições nanoparticuladas de isotretinoina

Info

Publication number
BR0117191A
BR0117191A BR0117191-7A BR0117191A BR0117191A BR 0117191 A BR0117191 A BR 0117191A BR 0117191 A BR0117191 A BR 0117191A BR 0117191 A BR0117191 A BR 0117191A
Authority
BR
Brazil
Prior art keywords
isotretinoin
nanoparticulate compositions
compositions
nanoparticulate
nanoparticulated
Prior art date
Application number
BR0117191-7A
Other languages
English (en)
Inventor
Inderdeep Bhatia
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0117191A publication Critical patent/BR0117191A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES NANOPARTICULADAS DE ISOTRETINOINA". A presente invenção refere-se à preparação de uma composição nanoparticulada de isotretinoína que possui biodisponibilidade aperfeiçoada.
BR0117191-7A 2001-12-06 2001-12-06 Composições nanoparticuladas de isotretinoina BR0117191A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/002329 WO2003047497A1 (en) 2001-12-06 2001-12-06 Isotretinoin nanoparticulate compositions

Publications (1)

Publication Number Publication Date
BR0117191A true BR0117191A (pt) 2005-05-10

Family

ID=11004222

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0117191-7A BR0117191A (pt) 2001-12-06 2001-12-06 Composições nanoparticuladas de isotretinoina

Country Status (7)

Country Link
US (1) US20050129773A1 (pt)
EP (1) EP1455730A4 (pt)
AU (1) AU2001298077A1 (pt)
BR (1) BR0117191A (pt)
EA (1) EA200400782A1 (pt)
MX (1) MXPA04005497A (pt)
WO (1) WO2003047497A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
WO2007086911A2 (en) * 2005-05-05 2007-08-02 Sanofi-Aventis U.S. Llc Stable nanoparticle formulations
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
WO2010109259A1 (es) * 2009-03-26 2010-09-30 Grufarcol Ltda Métoda para preparar formulaciones de gel blando de isotretinoína líquida y la formulaciones obtenidas
WO2010134048A2 (en) * 2009-05-20 2010-11-25 Ranbaxy Laboratories Limited Topical retinoid solutions
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
MA40312A (fr) * 2014-05-29 2017-04-05 Sun Pharmaceutical Ind Ltd Composition pharmaceutique orale d'isotrétinoïne
EP3148645A4 (en) * 2014-06-02 2017-11-15 Sun Pharmaceutical Industries Ltd Oral pharmaceutical composition of isotretinoin
JP2017521470A (ja) 2014-07-31 2017-08-03 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． イソトレチノインの経口医薬組成物
MA40781A (fr) * 2014-10-01 2017-08-08 Sun Pharmaceutical Ind Ltd Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
US9750711B2 (en) 2014-10-01 2017-09-05 Sun Pharmaceutical Industries Limited Low dose oral pharmaceutical composition of isotretinoin
BR112017025427A2 (pt) * 2015-05-25 2018-08-07 Sun Pharmaceutical Ind Ltd composição farmacêutica oral
EP4547241A1 (en) * 2022-07-01 2025-05-07 Acrotech Biopharma Inc. Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5429824A (en) * 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
CA2281837A1 (en) * 1999-09-07 2001-03-07 Bernard Charles Sherman Solid pharmaceutical composition comprising a retinoid and polyethylene glycol
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients

Also Published As

Publication number Publication date
EA200400782A1 (ru) 2005-08-25
EP1455730A1 (en) 2004-09-15
US20050129773A1 (en) 2005-06-16
AU2001298077A1 (en) 2003-06-17
MXPA04005497A (es) 2004-10-11
WO2003047497A1 (en) 2003-06-12
EP1455730A4 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
BR0010242A (pt) Composições quìmicas que atraem artrópodes
BR122016015715B8 (pt) composições farmacêuticas de metilamida de ácido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenóxi)-piridina-2-carboxílico
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BR0117191A (pt) Composições nanoparticuladas de isotretinoina
BR0313420A (pt) Quinolonas microbicidas, suas composições e usos
PL211243B6 (pl) Kompozycja farmaceutyczna antagonisty receptora tachykininy
BR0206955A (pt) Ligantes de receptores de canabinóides
IS6859A (is) Kristölluð form atorvastatíns
BR0213063A (pt) Antibióticos de ação dupla
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
BR0308979A (pt) Derivados de indolilmaleimida
CY1114535T1 (el) Ρετινοειδη παραγωγα με αντιαγγειογονικες, αντιογκικες και προαποπτωτικες δραστικοτητες
GT200300040A (es) Composicion de ziprasidona y controles sinteticos
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
BR0116319A (pt) Composição herbicida
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
NO20071152L (no) Lysinbaserte forbindelser
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0408848A (pt) formulações orais de cladribine
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
DE60209215D1 (de) Zusammensetzungen mit verbesserter farbstabilität die leucine enthalten
BR9915692A (pt) Monohidrato de bromidrato de eletriptano

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.